CMF2 Thyroid Nodules: What Molecular Markers are Most Useful?

Program: Case Management Forums
Clinical Session
Friday, April 1, 2016: 2:15 PM-3:00 PM
BR East (BCEC)
Friday, April 1, 2016: 3:30 PM-4:15 PM
BR East (BCEC)
Steven Paul Hodak, MD, NYU Langone Medical Center, New York, NY and Bryan McIver, MB, ChB, PhD, Moffitt Cancer Center, Tampa, FL

BM: Consultant, Veracyte, Inc., Consultant, Asuragen, Consultant, CBL Path. Nothing to Disclose: SPH
See more of: Case Management Forums


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire